Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Summit Therapeutics Inc. | Director | Common Stock | 10M | $25.1M | $2.51 | Jan 17, 2023 | Akeso, Inc. |
Summit Therapeutics Inc. | Director | Stock Option (right to buy) | 235K | $310K | $1.32 | Jan 2, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
SMMT | Summit Therapeutics Inc. | Jan 2, 2024 | 2 | $0 | 4 | Jan 4, 2024 | Director |
SMMT | Summit Therapeutics Inc. | Dec 31, 2023 | 2 | $47.7M | 5 | Feb 14, 2024 | Director |
SMMT | Summit Therapeutics Inc. | Jan 17, 2023 | 0 | $0 | 3 | Jan 26, 2023 | Director |